Polar Capital Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Sell |
2,109,177
-240,823
| -10% | -$1.57M | 0.07% | 167 |
|
|
2025
Q1 | $18.6M | Buy |
2,350,000
+2,165,000
| +1,170% | +$17.2M | 0.11% | 153 |
|
|
2024
Q4 | $2.34M | Hold |
185,000
| – | – | 0.01% | 264 |
|
|
2024
Q3 | $2.58M | Sell |
185,000
-750,000
| -80% | -$10.4M | 0.01% | 261 |
|
|
2024
Q2 | $12.9M | Sell |
935,000
-250,000
| -21% | -$3.45M | 0.08% | 167 |
|
|
2024
Q1 | $19.6M | Sell |
1,185,000
-200,000
| -14% | -$3.3M | 0.1% | 147 |
|
|
2023
Q4 | $20.2M | Sell |
1,385,000
-550,000
| -28% | -$8.03M | 0.12% | 134 |
|
|
2023
Q3 | $23.7M | Buy |
1,935,000
+160,385
| +9% | +$1.97M | 0.18% | 126 |
|
|
2023
Q2 | $21.2M | Buy |
1,774,615
+375,067
| +27% | +$4.48M | 0.11% | 146 |
|
|
2023
Q1 | $18.7M | Hold |
1,399,548
| – | – | 0.12% | 144 |
|
|
2022
Q4 | $30.1M | Buy |
1,399,548
+163,973
| +13% | +$3.53M | 0.24% | 114 |
|
|
2022
Q3 | $24.7K | Buy |
1,235,575
+263,879
| +27% | +$5.29K | 0.16% | 125 |
|
|
2022
Q2 | $17.4K | Buy |
+971,696
| New | +$17.4K | 0.1% | 156 |
|